| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/17/2003 | US20030073930 Methods and device for preventing or healing injured nipples or areolas in mammalian females or for obtaining samples from nipples in mammalian females |
| 04/17/2003 | US20030073826 Crystaline clindamycin free base |
| 04/17/2003 | US20030073825 Azalide antibiotic compositions |
| 04/17/2003 | US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
| 04/17/2003 | US20030073715 Nasal administering; side effect reduction |
| 04/17/2003 | US20030073714 Prevent drug abruse; side effect reduction; administering mixture of opioid antagonist, releasable form and sequestering agent |
| 04/17/2003 | US20030073676 Dissolving in aqueous carrier; antiallergens |
| 04/17/2003 | US20030073670 Aqueous solution |
| 04/17/2003 | US20030073665 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 04/17/2003 | US20030073651 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 04/17/2003 | US20030073648 Crystaline clindamycin free base |
| 04/17/2003 | US20030073647 Crystaline clindamycin free base |
| 04/17/2003 | US20030073642 Methods and formulations for delivery of pharmacologically active agents |
| 04/17/2003 | US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 04/17/2003 | US20030073625 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides |
| 04/17/2003 | US20030073619 Branched polyethylenimine |
| 04/17/2003 | US20030073609 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 04/17/2003 | US20030073608 Alzheimer's disease; administering neurotransmitter antagonist |
| 04/17/2003 | US20030073594 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
| 04/17/2003 | US20030073238 Apparatus and method for electroporation of biological samples |
| 04/17/2003 | US20030072841 Polybutene containing chewing gum and confection |
| 04/17/2003 | US20030072821 Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer |
| 04/17/2003 | US20030072818 For inhibiting platelet aggregation, for prolonging bleeding time |
| 04/17/2003 | US20030072814 Topical pharmaceutical composition for the treatment of warts |
| 04/17/2003 | US20030072810 Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| 04/17/2003 | US20030072809 Introducing a mixture of medicament and excipients comprising crystalline cellulose into high speed agitation granulator and spraying on water or a mixture of ethanol and water as binder solution to produce spherical granule |
| 04/17/2003 | US20030072808 Immediate release eplerenone compositions |
| 04/17/2003 | US20030072807 Solid particulate antifungal compositions for pharmaceutical use |
| 04/17/2003 | US20030072804 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body |
| 04/17/2003 | US20030072803 For therapy of excess weight, diabetes, high blood lipid level, artherial sclerosis, artherial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 04/17/2003 | US20030072802 For therapy of mania and depression |
| 04/17/2003 | US20030072801 Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| 04/17/2003 | US20030072800 Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 04/17/2003 | US20030072799 Placing supply of powder in flow communication with a die; applying suction to die cavity to cause powder to flow into die cavity, suction being applied to die cavity through filter; isolating filter from powder to form compressed dosage |
| 04/17/2003 | US20030072798 Drug delivery; bioavailability |
| 04/17/2003 | US20030072797 Pharmaceutical compositions for oral administration |
| 04/17/2003 | US20030072794 Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes |
| 04/17/2003 | US20030072793 Method for administering agents to the central nervous system |
| 04/17/2003 | US20030072792 Drug delivery |
| 04/17/2003 | US20030072791 Felodipine transdermal device and methods |
| 04/17/2003 | US20030072789 For towelette or wipes useful for feminine cleansing |
| 04/17/2003 | US20030072780 Cosmetic or pharmaceutical compositions for topical application to skin |
| 04/17/2003 | US20030072775 For immunization; for therapy of disseminated candidiasis |
| 04/17/2003 | US20030072768 Method to enhance an immune response of nucleic acid vaccination |
| 04/17/2003 | US20030072764 Mucosal boosting following parenteral priming |
| 04/17/2003 | US20030072731 Dip coating compositions containing starch or dextrin |
| 04/17/2003 | US20030072729 Simethicone as weight gain enhancer |
| 04/17/2003 | US20030072727 Composition and method for producing lubricating, germicide foam |
| 04/17/2003 | US20030072726 Phenolic compounds from natural biological materials such as plant material |
| 04/17/2003 | US20030072724 Topical pharmaceutical composition to treat hyperpigmentation of the skin |
| 04/17/2003 | US20030072718 Spray drying to produce stable, high-potency dry powder formulations; utility in pulmonary delivery of interferons |
| 04/17/2003 | US20030072716 Comprising carbohydrates and carbohydrate-based materials adapted to interact with carbon dioxide in gaseous, liquid and supercritical forms |
| 04/17/2003 | US20030070903 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/17/2003 | US20030070687 Encapsulated materials |
| 04/17/2003 | US20030070679 Capsules containing inhalable tiotropium |
| 04/17/2003 | US20030070621 Apparatus and method for producing a foam bovine teat dip |
| 04/17/2003 | US20030070584 Dip coating compositions containing cellulose ethers |
| 04/17/2003 | DE20300183U1 Sprayable formulation, useful e.g. as an immunostimulant or antidepressant, comprises medicinal plant extracts and a low concentration of ethanol |
| 04/17/2003 | DE20219663U1 Composition for oral administration, useful as pharmaceutical, food or food additive, comprises polymeric powder coated with hydrophilic liquid |
| 04/17/2003 | CA2788500A1 Modifications of solid 3-sn-phosphoglycerides |
| 04/17/2003 | CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 04/17/2003 | CA2463384A1 Hydrating nasal gel and applicator |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463168A1 An antispasmodic agent spaced drug delivery system |
| 04/17/2003 | CA2462886A1 Flashmelt oral dosage formulation |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2462582A1 Adjuvants for nucleic acid vaccines |
| 04/17/2003 | CA2462579A1 Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same |
| 04/17/2003 | CA2461291A1 Inhibition of exoprotein production using aromatic compositions |
| 04/17/2003 | CA2461048A1 Liposome-encapsulated insulin formulations |
| 04/17/2003 | CA2460690A1 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 04/17/2003 | CA2458473A1 Pharmaceutical formulation |
| 04/17/2003 | CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/16/2003 | WO2003032915A2 Viral inhibition by n-docosanol |
| 04/16/2003 | EP1302304A1 Nucleated molded article, method of producing the same, and device for producing the same |
| 04/16/2003 | EP1302205A1 Controlled release formulations of macrolide citrate salts |
| 04/16/2003 | EP1302202A2 Transdermal device for administration through de-epithelialized skin |
| 04/16/2003 | EP1302201A1 Pharmaceutical composition improved in peroral absorbability |
| 04/16/2003 | EP1302200A1 Pharmaceutical formulation of a budesonide-containing water-propylene glycol solution and method of preparing it |
| 04/16/2003 | EP1301638A1 Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| 04/16/2003 | EP1301593A2 ANTISENSE COMPOSITIONS TARGETED TO $g(b) 1? ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 04/16/2003 | EP1301238A1 Vaccines |
| 04/16/2003 | EP1301226A2 Kits and compositions supporting intracranial perfusions |
| 04/16/2003 | EP1301210A2 Compositions containing therapeutically active components having enhanced solubility |
| 04/16/2003 | EP1301209A1 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 04/16/2003 | EP1301200A2 Peptide pharmaceutical formulations |
| 04/16/2003 | EP1301193A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 04/16/2003 | EP1301186A1 Sildenafil citrate solid dispersions having high water solubility |
| 04/16/2003 | EP1301180A2 Film dermatics |
| 04/16/2003 | EP1301179A2 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 04/16/2003 | EP1301178A2 Delivery device |
| 04/16/2003 | EP1301177A2 Method and materials for controlling migration of binder liquid in a powder |
| 04/16/2003 | EP1301176A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
| 04/16/2003 | EP1301175A2 Suppository and composition comprising at least one polyethylene glycol |
| 04/16/2003 | EP1301174A1 Fast release bioadhesive microspheres for the sublingual administration of proximate principles |
| 04/16/2003 | EP1301173A1 A medicinal aerosol formulation |
| 04/16/2003 | EP1301150A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 04/16/2003 | EP1301077A2 Antimicrobial composition useful for the treatment of bovine mastitis |
| 04/16/2003 | EP1185254B1 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 04/16/2003 | EP1158967B1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |